Tech Company Financing Transactions
Civetta Therapeutics Funding Round
Deerfield Capital participated in a $53 million Series A funding round for Civetta Therapeutics. The round was announced by the company on 12/5/2019.
Transaction Overview
Company Name
Announced On
12/5/2019
Transaction Type
Venture Equity
Amount
$53,000,000
Round
Series A
Investors
Proceeds Purpose
The Series A funding will position the company to further validate its platform, advance lead programs, secure permanent facilities, and expand the research team.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
650 East Kendall St. 2nd Floor
Cambridge, MA 02142
USA
Cambridge, MA 02142
USA
Phone
Undisclosed
Website
Email Address
Overview
Civetta Therapeutics was founded by William Sellers (Broad Institute and Dana-Farber Cancer Institute) and Eric Fischer (Dana Farber Cancer Institute and Harvard Medical School) to advance new medicines through small molecule intervention targeting propeller domains with the goal of developing important therapeutics for cancer and other indications.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Bruce Goldsmith
Co-Founder
Eric Fischer
Co-Founder
William Sellers
Vice President
Andrew Cook
Vice President
Joseph Kelleher
Browse more venture capital transactions:
Prev: 12/5/2019: Augtera Networks venture capital transaction
Next: 12/5/2019: Delphia venture capital transaction
Share this article
Where The Data Comes From
We do our best to report on every notable VC transaction. VC investment data records on this site are sourced from company press releases and news coverage. The data is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs